Supplement study explores metabolic changes in healthy volunteers
NCT ID NCT06840080
First seen Nov 18, 2025 · Last updated May 13, 2026 · Updated 22 times
Summary
This completed study looked at how a supplement called oleoylethanolamide (OEA) with LipiSperse affects certain metabolic markers in healthy adults aged 30 and older with a BMI between 25 and 35. Forty participants were given the supplement or a placebo in a crossover design. The goal was to measure changes in blood levels of GLP-1 and other metabolic substances, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS - MALE AND FEMALE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
RDC Clinical
Brisbane, Queensland, 4006, Australia
Conditions
Explore the condition pages connected to this study.